Business
Pfizer ends COVID-19 vaccine trial with 95 per cent efficacy – Sydney Morning Herald
Effectiveness of the vaccine was consistent across age and ethnicity demographics, and that there were no major side effects, a sign that the immunisation could…
The better-than-expected data from the two vaccines, both developed with new technology known as messenger RNA (mRNA), have raised hopes for an end to a resurgent pandemic that has killed more than 1.3 million people globally and wreaked havoc upon economies and daily life.
However, while some groups such as healthcare workers will be prioritised in the United States for vaccinations this year, it will be months before large-scale rollouts begin.
Pfizer said on Wednesday there had been 170 cases…
-
Noosa News15 hours agoProtest calls for shark net removal
-
General14 hours agoThree youths in police custody after fire at Ashley Youth Detention Centre in northern Tasmania
-
Noosa News16 hours agoNew playground equipment encourages children to learn through ‘risky play’
-
General19 hours agoVigils mark Israel attack anniversary, Gaza death toll